| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |